Results 31 to 40 of about 32,738 (145)
Analysis of Differentially Expressed Proteins in Self-Paired Sera of Advanced Non-small Cell Lung Cancer Patients Responsive to Gefin [PDF]
Background and objective All the advanced NSCLC patients that received EGFR-TKI therapy will eventually relapse after a period of efficacy. The aim of this study is to investigate the serum biomarkers as potential predictive factors for the efficacy of ...
Ailin GUO +10 more
core
ABSTRACT Periodontitis is a chronic infectious oral disease triggered by periodontopathogenic bacteria, resulting in the progressive inflammation and destruction of the tissues surrounding teeth. To achieve reprogramming of the infectious microenvironment for periodontitis therapy, a nanoformulation was proposed by loading polydopamine (PDA) with ...
Hao Liang +14 more
wiley +1 more source
The study on the mechanism of topical propranolol gel in therapy of superficial infantile hemangiomas [PDF]
目的:探讨外涂普萘洛尔凝胶对浅表型婴幼儿血管瘤(IHs)患儿血浆碱性成纤维生长因子(bFGF)、基质金属蛋白酶-9(MMP-9)、血管内皮生长因子(VEGF)、肾素和血管紧张素Ⅱ(ATⅡ)水平的影响。初步探讨普萘洛尔凝胶治疗婴幼儿血管瘤的可能机制,以寻找治疗婴幼儿血管瘤高选择性用药,减少不良反应的发生。 方法:选取2013年2月至2014年2月厦门大学附属东方医院普通外科接受普萘洛尔凝胶治疗的33例婴幼儿血管瘤患儿,采用Achauer分级标准评估疗效,酶联免疫吸附试验(ELISA)检测患儿治疗前 ...
唐玉娟
core
ABSTRACT Narrowband near‐infrared (NIR) phosphor‐converted light‐emitting diodes (pc‐LEDs) featuring low full‐width at half maximum (FWHM) and high conversion efficiency are crucial for chemical content evaluation, light therapy, and bioimaging.
Chunshen Li +4 more
wiley +1 more source
【目的】探讨难治性斑秃患者局部外用二苯环丙烯酮(DPCP)的疗效及其影响因素。【方法】回顾性分析127例难治性斑秃患者外用DPCP的有效率、不良反应、复发率和再次治疗的有效率,并分析临床资料、皮肤镜征象、检验指标对疗效的影响。【结果】本组难治性斑秃患者DPCP 治疗治愈率、有效率分别为37.1%、44.8%,复发率为36.5%,复发后再治疗有效率为63.2%。26.8%患者出现较明显副作用如严重接触性皮炎、泛发性接触性皮炎、白癜风等。发病年龄早、病程长、稳定期、脱发面积大、斑秃类型为全普秃和带状型 ...
詹济滂 +5 more
doaj
A Systematic Review on Different Treatment Methods of Bone Metastasis from Cancers [PDF]
Background and objective Skeletal metastase is one of the most common complications related to advanced cancer. The aim of this study is to analyze the effectiveness and safety of radiotherapy plus intravenous bisphosphonates versus radiotherapy alone ...
Jinhui TIAN +4 more
core
ABSTRACT Lung cancer remains the leading cause of cancer‐related deaths worldwide, yet immune checkpoint blockade (ICB) is often compromised by an immunosuppressive tumor microenvironment (TME) with acidosis, hypoxia, and poor T cell infiltration. Here, we develop a TME‐responsive nanoplatform (MgH2@Lip/PD‐L1) that couples hydrogen gas therapy with PD ...
Xuyu Gu +5 more
wiley +1 more source
: 【目的】探讨复合声对听阈正常耳鸣患者的疗效,为纯音听阈正常耳鸣患者治疗提供参考。【方法】 收集2014年9月1日-2015年12月30日间中山大学附属第一医院门诊就诊的纯音测听听阈正常的46例耳鸣患 者,耳鸣持续时间>3个月。详细收集患者病例资料如年龄、性别、耳鸣特点、伴随症状等,并行纯音测听、耳鸣测 听检查,以及耳鸣致残量表(THI)评分和视觉模拟评分(VAS)评分。给予复合声治疗,选取主频与耳鸣频率一致 的自然声,并挑选音乐主频覆盖耳鸣频率中心的音乐片段 ...
李昌武 +3 more
doaj
The Analysis of Erlotinib on Brain Metastases in Patients with Non-small-cell Lung Cancer [PDF]
Background and objective Brain metastases are common in non-small-cell lung cancer (NSCLC) and the prognosis is poor. Erlotinib is a specific inhibitor of the epidermal growth factor receptor-associated tyrosine kinase (EGFRTKI), which has been gradually
Baohui HAN, Hao BAI
core
Fetoscopic laser ablation vs standard management for Type‐II and Type‐III vasa previa
ABSTRACT Objective The standard management (SM) for vasa previa (VP) includes antepartum inpatient admission at 28–32 weeks' gestation followed by Cesarean delivery at 34–37 weeks. Case reports and case series have reported on fetoscopic laser ablation (FLA) as an alternative management approach for Types‐II and ‐III VP.
S. Backley +11 more
wiley +1 more source

